The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...

The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...

Among patients with LVO-related AIS undergoing EVT, general anesthesia is linked to better 90-day recovery and functional independence vs sedation.

Controversial anti-amyloid therapies costing up to $32,000 annually offer modest hope for Alzheimer's patients while carrying ...

Taking a pleasant daily stroll could help slow the protein buildup and cognitive decline associated with Alzheimer's disease, ...

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major ...

WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...

In a 36-year-old woman with a resected 5-cm, node-negative, estrogen-receptor (ER)-negative, progesterone-receptor (PR)-positive, HER2-neu-negative breast cancer, is there a role for the addition of ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.

People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared to those on other diabetes medications The protective effects were strongest in younger ...

Healthcare ambulatory boom drives hospitals to treat sicker patients and redesign inpatient care models for efficiency and safety.